# Diaphragm Function After Reversal of Rocuronium-induced Neuromuscular Blockade With Sugammadex or Neostigmine in Children

> **NCT05724550** · NA · COMPLETED · sponsor: **Seoul National University Hospital** · enrollment: 73 (actual)

## Conditions studied

- Neuromuscular Block, Residual

## Interventions

- **DRUG:** Sugammadex
- **DRUG:** Neostigmine

## Key facts

- **NCT ID:** NCT05724550
- **Lead sponsor:** Seoul National University Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-02-22
- **Primary completion:** 2024-06-07
- **Final completion:** 2024-06-08
- **Target enrollment:** 73 (ACTUAL)
- **Last updated:** 2025-04-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05724550

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05724550, "Diaphragm Function After Reversal of Rocuronium-induced Neuromuscular Blockade With Sugammadex or Neostigmine in Children". Retrieved via AI Analytics 2026-06-29 from https://api.ai-analytics.org/clinical/NCT05724550. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*